Fundz

Re:Course Ai Lands $4.3 Million For Healthcare's Answer To Ai Flight Simulators

PRIVATEFeb 03, 2023

Amount Raised

$4.3 Million

Round Type

Seed

Health CareArtificial IntelligenceMedical

Investors

Nhs England's Sbri Healthcare UnitGMC Life Sciences Fund By PraeturaNorthern Gritstone

Description

Billed as medical training's very own AI flight simulator, Manchester-based Re:course AI has locked down $4.3 million in seed funds to build foreign market share for its "generative AI" tuition product.

Quick answer

Re:course AI raised $4.3 Million in a Seed round, dated February 3, 2023. Investors: Nhs England's Sbri Healthcare Unit, GMC Life Sciences Fund By Praetura and Northern Gritstone.

How much did Re:course AI raise?
Re:course AI raised $4.3 Million in a Seed round on February 3, 2023.
Who invested in Re:course AI?
Nhs England's Sbri Healthcare Unit, GMC Life Sciences Fund By Praetura and Northern Gritstone are named as investors in this round.
What does Re:course AI do?
We're developing the healthcare workforce of the future using AI-powered simulation technology.

Source: Fundz verified event record.

Who else raised in Medical and Health Care around the same time

Companies in the same sectors as Re:course AI that raised within 45 days of this round, from Fundz verified event records.

  • OpenLoop raised $15M (Funding Round) on March 16, 2023.
  • Health Plix raised $22M (Funding Round) on March 15, 2023.
  • Predicta Med raised an undisclosed amount (Funding Round) on February 10, 2023.
  • Incepto raised $3M (Seed) on February 3, 2023.
  • Stride raised $750K (Seed) on February 3, 2023.
  • OpenLoop raised $368K (Seed) on December 28, 2022.

Who to call at Re:course AI, and when

A new round usually means Re:course AI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Re:course AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Re:course AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Re:course AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Re:course AI

About

We're developing the healthcare workforce of the future using AI-powered simulation technology. The Recourse experiential skills development platform instantly lets clinicians put theory into practice, using conversational Digital Humans to simulate complex interactions. With instant feedback anytime, anywhere, we support healthcare & life science organisations to achieve optimal performance.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Re:course AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Re:course AI's next move

See what Strategic adds

Re:course AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.